MagVenture announced today that it launched the patent-pending MagVenture Flow Arm for brain stimulation positioning.
Alpharetta, Ga.-based MagVenture’s Flow Arm clinical positioning system is designed to optimize the delivery of the company’s FDA-cleared protocols for non-invasive brain stimulation technology in treating major depressive disorder and as an adjunct therapy for OCD, according to a news release.
The MagVenture Flow Arm is touted by the company as the latest improvement to its MagVenture TMS (transcranial magnetic stimulation) Therapy system. It improves upon the applicator “coil,” which is usually large and unwieldy, the company said.
MagVenture said the coil is essentially comprised of two heavy spools of copper wire that produce and focus magnetic fields for the brain stimulation. The coil has to be accurately positioned and held immobile over the brain targets during TMS procedures.